Anthropic IPO filing warns of existential risk and shows a $42 billion loss

Anthropic warned of AI’s existential risk to humans in its IPO filing¹, telling investors in the prospectus that AI models could pose existential risks². The company filed confidentially for an initial public offering at a valuation that the filing describes⁴, reported elsewhere as a 2 trillion dollar valuation alongside a ballooning net loss and disclosed AI risks in the leaked IPO papers⁷.

The loss is the headline financial disclosure: 42 billion dollars, which Forbes attributed to Google and Amazon³. The prospectus shows a giant loss and an even bigger ask⁴.

It also reveals a concentration problem. Anthropic relies on Amazon and Google for nearly half its sales⁵, with nearly 50 percent of sales flowing through those channels⁸.

Why it matters to investors

A risk factor that names existential risk to humans^1,2 is an unusual disclosure for a company seeking public capital, and it is consistent with the chief executive’s public position rather than at odds with it. The filing follows calls for a coordinated slowdown in AI development by Chief Executive Dario Amodei, echoed by rivals including OpenAI’s Sam Altman^1,7.

The revenue concentration is the more conventional worry. Nearly half of sales running through Amazon and Google^5,8 means the two companies are simultaneously suppliers, investors and distribution, and Forbes identified them as the cause of the loss³.

Politics is also on the risk list. Amodei engaged in a high-profile standoff with the Department of War earlier this year over the Pentagon’s ability to use Anthropic’s AI for domestic purposes³.

What to watch

The size of the ask against the size of the loss is the first test. The prospectus pairs a giant loss with an even bigger capital request⁴, at a valuation reported in the trillions⁷.

The second is what the listing says about the wider market. Business Insider contrasted Anthropic racing toward a massive IPO with the wearables company Oura hitting pause, describing the pair as exposing a stock market breadth problem⁶.

The third is whether the concentration eases before pricing. Nearly half of revenue depends on two counterparties^5,8 that the filing also identifies as central to its cost base³. Investors will want to see whether that dependence is presented as a transitional feature or a structural one, and how the existential-risk language sits with underwriters^1,2.